−1.18 M USD
0.00 USD
18.11 M
About Vicapsys Life Sciences, Inc.
Sector
CEO
Federico Luis Pier
Headquarters
Suwanee
Website
Founded
1996
FIGI
BBG000C5W9D5
Vicapsys Life Sciences, Inc. is a development stage biotechnology company, which advances proprietary localized immune modulator. Its product name VICAPSYN is the firm's line of proprietary product candidates that is applied to transplantation therapies and related stem-cell applications in the transplantation field. The firm's lead product candidate embodiment in transplantation therapy to treat Type 1 Diabetes is an encapsulated human islet cell cluster that is intended to restore normal glucose control when implanted into the peritoneal cavity of a patient. The company was founded on December 26, 1996 and is headquartered in Suwanee, GA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VICP is 0.000001 USD — it has decreased by −100.00% in the past 24 hours. Watch Vicapsys Life Sciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Vicapsys Life Sciences, Inc. stocks are traded under the ticker VICP.
VICP stock has fallen by −100.00% compared to the previous week, the month change is a −100.00% fall, over the last year Vicapsys Life Sciences, Inc. has showed a −100.00% decrease.
VICP reached its all-time high on Jun 12, 1998 with the price of 35,876.025000 USD, and its all-time low was 0.000100 USD and was reached on Jul 20, 2021. View more price dynamics on VICP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VICP stock is 151.00 M% volatile and has beta coefficient of 3.11. Track Vicapsys Life Sciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Vicapsys Life Sciences, Inc. there?
Yes, you can track Vicapsys Life Sciences, Inc. financials in yearly and quarterly reports right on TradingView.
No, VICP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 15, 2024, the company has 2.00 employees. See our rating of the largest employees — is Vicapsys Life Sciences, Inc. on this list?
Like other stocks, VICP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Vicapsys Life Sciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Vicapsys Life Sciences, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Vicapsys Life Sciences, Inc. stock shows the strong sell signal. See more of Vicapsys Life Sciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.